Page 1 of 2 · Site & Audience Overview
KCLEAGENICS MEDICAL is a specialist oncology CRO with a growing digital platform reaching oncology clinicians, research coordinators, and cancer patients actively researching clinical trial options. This media kit outlines our audience, content reach, and partnership capabilities for sponsors and CROs seeking to accelerate trial accrual.
Medical oncologists, haematologists, and oncology subspecialists reviewing protocol and research content. Primary referrers for trial enrolment decisions.
Patients diagnosed with cancer actively researching trial options — a self-referred, high-intent audience specifically seeking clinical trial access information.
Site-level clinical research staff seeking GCP education, protocol resources, and trial operations guidance. Primary consumers of our education and blog content.
Primary care physicians, oncology nurses, and patient advocates seeking trial referral pathways and plain-language eligibility information for their patients.
Active protocol listings, eligibility summaries, and recruitment status pages — highest purchase-intent traffic on the site.
GCP, protocol execution, biospecimen, and trial operations content for clinical research professionals. Searchable, indexed.
Peer-referenced clinical commentary covering NSCLC, haematology, GI, liquid biopsy, and emerging oncology data.
Plain-language trial navigation for patients — eligibility guides, "what to expect" content, and self-referral registration.
Referral tools, trial summaries, and clinical intelligence resources for oncologists and research coordinators.
Monthly Clinical Intelligence Briefing — curated trial updates, methodology insights, and sponsored protocol features. Exclusive per issue.
Page 2 of 2 · Placement & Referral Capabilities
Exclusive protocol section, monthly send
Homepage + condition pages + trial listing
Sponsored editorial, permanently indexed
Patients matched from our registry by tumour type, biomarker profile, and prior treatment history. Warm referral — not anonymous ad traffic.
Oncologists and coordinators in our network briefed on your open protocol with plain-language eligibility summaries and pre-screen tools.
Patients complete a structured pre-screen mapped to your criteria. We triage and forward only screen-plausible candidates — reducing screen failure burden.
Outreach volume, pre-screen completions, screen-eligible referrals, and conversion by channel. All campaigns operate on flat-fee service terms (AKS compliant).
We respond within one business day with available slots, a quoted rate for the packages you select, and a sample placement mockup for your therapeutic area.